18 eredmény a kulcsszóra: 'epidermal growth factor egf'
The author has examined the effect of the signal transduction molecules as: IGF ((Insulin-like Growth Factor), EGF (Epidermal Growth Factor), VEGF (Vascular Endothelia Growth
N/A
At indicated times thereafter duplicate dishes from cultures growing in the presence (o) or absence (·) of hEGF were removed and the cell numbers determined. At the times
N/A
(2008) Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma. (2007) Epidermal growth factor receptor copy number
N/A
(1993) Effects of epidermal growth factor, insulin-like growth factor-I, and dialysed porcine follicular fluid on porcine oocyte maturation in vitro. (1988) Coculture
N/A
In Education and Technology – key issues and debates Neil Selwyn summarises current and highly-disputed topics in the field of educational technology.. It explores problem
N/A
DFS = (disease-free survival) betegségmentes túlélés; EGFR = (epidermal growth factor receptor) epidermális növekedési fak- tor receptor; EMA = epithelialis membránantigén; FIGO =
N/A
Binding interactions between human serum albumin (HSA) and four approved epidermal growth factor receptor (EGFR) inhibitors gefitinib (GEF), erlotinib (ERL), afatinib (AFA),
N/A
Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas. ORAL
N/A
S1 X-ray diffractometry patterns of diclofenac anion-intercalated LDH samples intercalated in ethanol-water mixtures of varying compositions (1:1 Fe(III):diclofenac
N/A
Aim To evaluate (I) trastuzumab-containing primary systemic therapy (PST) in human epidermal growth factor receptor 2 (Her2) overexpressing breast carcinomas.; (II)
N/A
Logit regression on the correlation between the recombinant human epidermal growth factor (rhEGF) application frequency (horizontal axis—measured in weeks) and complete healing
N/A
When epidermal growth factor receptor (EGFR) mutation was detected in patients with pulmonary adenocarcinomas and subsequent specific treatment with tyrosine kinase inhibitors
N/A
(2006) Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinib. Clinical cancer research :
N/A
(2013) Notch-1 contributes to epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance in non-small cell lung cancer in vitro and in vivo.. Tanizaki
N/A
(2012) Rare and complex mutations of epidermal growth factor receptor (EGFR) and efficacy of tyrosine kinase inhibitor (TKI) in patients with non-small cell lung cancer
N/A
Pooled Analysis of the Prognostic and Predictive Value of KRAS Mutation Status and Mutation Subtype in Patients with Non-Small Cell Lung Cancer Treated with Epidermal Growth
N/A
(E) HaCaT cells were stimulated with thapsigargin in the presence of 600 or 1200 U/ml catalase and then processed for Trx1 western blot as described above. This experiment
N/A